The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Are we not already in a dip! How much lower are we expecting this share to fall? Rights issue/open offer to come will no doubt keep the share price down but are not the prospects better than a lot of AIM stocks?
Surely this one has a chance to make long term investors (ok only 2 years!) some profit?
AIM investment isn’t for the faint hearted. Very sad to see the demise of this local company. Personally I don’t blame NR for being enthusiastic about his company but perhaps the board couldn’t keep him being perhaps over confident. Whilst he’s getting paid a wage as no doubt his contract requires he’s probably lost more than anyone in financial and credibility terms. I sold my modest holding this morning as I don’t want a deferred share complicating matters ( will they be held outside ISA?) but wish the company well in its survival. The loss is still painful but my investment judgement even more hurt!
Anyone attend the site visit at Wickwar today and get a sense of how trading is going?
Going from AIM to main market normally means a positive for the share price but very subdued at present. Can’t all be to do with economic activity.
Surely surely they can get one of these projects over the line after taking over 10 years and £62 m to get there.
How much will the AGM Plaza Venus cost?!
Share price seems unimpressed with all the words in the annual report.
We so want this co to succeed and yet by next summer the cap will be passed round again.
I take your point but Directa seem to be a bit further down the road. (Recent results) With so much research and development costs surely being duplicated would it not make sense to merge to survive?
Perhaps I spoke too soon. Share suspension not a good place to be in whatever the reasons.
Yesterdays uncalled for share price reaction now corrected. We may even be on the way to seeing an AiM stock where I’m seeing a profit !!
RNS all positive and figures for year ahead confirmed as achievable. Directors normally say at AGMs when asked ‘we have no control over the share price’. So if someone attends today could they see if there is a different response!
With this announcement we seem to be really gearing up the production line. When will the market recognise the potential in this company?!
Yes could have been worse and the sales increase in certain area is encouraging. This is a cyclical stock but cash in the bank enables further investment in growth area and the new site will hopefully reduce costs in the future.
Comment that Chief Exec paid too much and share price not moving in line with EPS. May be true and with AGM next week? would do no harm asking some pertinent questions.Or move to Wall Street to the dismay of UK new defence minister!